Tip: to make this exercise more difficult, place a circle band just above or below the knees
As a glucagon-like peptide-1 ( GLP-1 ) receptor agonist, it works by mimicking the natural GLP-1 hormone in the body and, in doing so, delays gastric emptying (i.e
Cagrilintide adds amylin receptor activation for additional appetite suppression and metabolic modulation
Both omeprazole and esomeprazole inhibit CYP2C19, leading to: Reduced formation of active clopidogrel metabolite Decreased antiplatelet efficacy Increased risk of thrombotic events (MI, stroke, stent thrombosis) Clinical takeaway: When gastric protection is required in patients on clopidogrel, consider safer alternatives such as: Pantoprazole Rabeprazole This simple switch can significantly improve therapeutic outcomes and patient safety
And also, I know that even the WHO these days are thinking about trying to develop GLP-1s for solving the problem of the global obesity